Patrick J. Christmas insider trades

Open-market stock purchases and sales by Patrick J. Christmas, Chief Strategy & Legal Officer at REGENXBIO Inc, from SEC Form 4 filings since May 16, 2011.

Recent trades

DateStockTradeValue
Aug 1, 2026RGNX REGENXBIO IncSold (not open market)$45.5K
Feb 1, 2026RGNX REGENXBIO IncSold (not open market)$52.5K
Jan 6, 2026RGNX REGENXBIO IncBought (not open market)—
Jan 6, 2026RGNX REGENXBIO IncBought (not open market)—
Jan 2, 2026RGNX REGENXBIO IncSold (not open market)$141K

Companies traded

  • RGNX REGENXBIO Inc: 34 sales, last Aug 1, 2026
  • KVA/KVB K-V Pharmaceutical Co: other filings, last Sep 27, 2013
  • KVA KV Pharmaceutical Co /de/: other filings, last Mar 28, 2012

Get free alerts when Patrick J. Christmas files a new trade →